Skip to content

Tectonic Therapeutics TECX Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-31.4%
Return on assets-29.7%+6.1pp-35.8%-5.6pp-30.2%-3.2pp-27%+1.8pp-28.8%+31.5pp
Liquidity
Current ratio18.5×-8.1×26.6×-2.5×29.2×+3.6×25.6×+2.7×22.9×+10.3×
Quick ratio18.5×-8.1×26.6×-2.5×29.2×+3.6×25.6×+2.7×22.9×+10.3×
Cash ratio18.3×-8.0×26.3×-2.5×28.8×+3.4×25.3×+2.6×22.7×+10.5×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Interest coverage-1,824.3×-490×-1,333.9×-286×-1,048.1×-164×-884×-217×-666.8×-119×
Per Share
Book value per share$12.28-10.5%$13.72-4.1%$14.30-5.9%$15.19-13.4%$17.55+5.8%
Valuation
Market capitalization$585.51M+58.3%$390.42M+33.0%$293.59M
Enterprise value$353.51M+438%$138.24M+446%$25.32M
Price / book2.5×+1.3×1.6×+0.5×1.1×
Free cash flow yield-11.2%+5.8pp-15.4%+5.9pp-21.3%
Earnings yield-14.3%+1.6pp-19%+3.9pp-22.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Tectonic Therapeutics's ratios come from?
Every ratio is computed from Tectonic Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.